Barely Significant
← all excerpts

Vectored delivery of anti-SIV envelope targeting mAb via AAV8 protects rhesus macaques from repeated limiting dose intrarectal swarm SIVsmE660 challenge.

PLoS Pathog · 2018 · PMC6296672 · PMID 30517201

1
hedged sentence
0.2370
closest p · 4.7× alpha
0.2370
boldest claim

The sentences

showed a trendp = 0.237not close (p > 0.1)
The mAb pretreatment showed a trend towards a similar level of protection versus contemporaneous controls (75%, p = 0.237), with 2 infections in 20 challenges.

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.